🇺🇸 FDA
Pipeline program

UMULINE NPH

P031006

Unknown small_molecule terminated

Quick answer

UMULINE NPH for Type 2 Diabetes is a Unknown program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Type 2 Diabetes
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials